C. Gu

发表

PCA3 rs544190G>A and prostate cancer risk in an eastern Chinese population

B. Dai, D. Ye, Yao Zhu, 2018, International braz j urol : official journal of the Brazilian Society of Urology.

Polymorphisms in nucleotide excision repair genes and risk of primary prostate cancer in Chinese Han populations

Q. Wei, D. Ye, Ya-jun Yang, 2016, Oncotarget.

Serum lipid profiles: novel biomarkers predicting advanced prostate cancer in patients receiving radical prostatectomy

B. Dai, D. Ye, Hai-Liang Zhang, 2014, Asian journal of andrology.

Prevalence of dyslipidaemia in patients with renal cell carcinoma: a case‐control study in China

D. Ye, Hai-Liang Zhang, Yao Zhu, 2014, BJU international.

The Rare Variant rs35356162 in UHRF1BP1 Increases Bladder Cancer Risk in Han Chinese Population

Jianfeng Xu, D. Ye, Meilin Wang, 2020, Frontiers in Oncology.

MTHFR c.677C>T Inhibits Cell Proliferation and Decreases Prostate Cancer Susceptibility in the Han Chinese Population in Shanghai

B. Dai, D. Ye, Hai-Liang Zhang, 2016, Scientific Reports.

Genetic variations of the ADIPOQ gene and risk of prostate cancer in Chinese Han men

D. Ye, Jiucun Wang, Li Jin, 2014, Asian journal of andrology.

Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients

Y. Zhu, D. Ye, Yao Zhu, 2016, Medicine.

Genetic variants in RTEL1 influencing telomere length are associated with prostate cancer risk

D. Ye, G. Lin, Yao Zhu, 2019, Journal of Cancer.

Clinical significance of urine prostatic exosomal protein in the diagnosis of prostate cancer.

D. Ye, Yao Zhu, X. Qin, 2019, American journal of cancer research.

Diagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese population

B. Dai, Xiaoyan Zhou, D. Ye, 2016, Scientific Reports.

Population-Based Assessment of the Number of Lymph Nodes Removed in the Treatment of Penile Squamous Cell Carcinoma

D. Ye, Yao Zhu, C. Gu, 2013, Urologia Internationalis.

The association between metabolic syndrome and advanced prostate cancer in Chinese patients receiving radical prostatectomy

D. Ye, Yao Zhu, X. Qin, 2015, Asian journal of andrology.

Identification of low-frequency variants of UGT1A3 associated with bladder cancer risk by next-generation sequencing

C. Qin, Q. Lv, D. Ye, 2021, Oncogene.

Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer

X. Yao, B. Dai, Yi-jun Shen, 2014, World Journal of Surgical Oncology.

Genetic variants in insulin-like growth factor binding protein-3 are associated with prostate cancer susceptibility in Eastern Chinese Han men

Jianfeng Xu, D. Ye, Yao Zhu, 2015, OncoTargets and therapy.

The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma

B. Dai, D. Ye, G. Lin, 2022, Molecular medicine.

A single nucleotide polymorphism in ADIPOQ predicts biochemical recurrence after radical prostatectomy in localized prostate cancer

D. Ye, Yao Zhu, Y. Qu, 2015, Oncotarget.

Clinicopathological characteristics and loss of mismatch repair protein expression in Chinese upper tract urothelial carcinomas

Y. Zhu, Yi-jun Shen, C. Yang, 2022, Frontiers in Oncology.

The expression and prognostic value of transporter 1, ATP binding cassette subfamily B member in clear cell renal cell cancer with experimental validation

D. Ye, G. Shi, Kun Chang, 2022, Frontiers in Oncology.

A single nucleotide polymorphism in CYP1B1 leads to differential prostate cancer risk and telomere length

Y. Zhu, D. Ye, Yao Zhu, 2018, Journal of Cancer.

Application of Internet-based multidisciplinary management in patients with genitourinary cancers in China: A brief introduction to a new model of healthcare service for cancer survivors during COVID-19 pandemic

X. Qin, C. Gu, Shengming Jin, 2022, Frontiers in Public Health.

Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer

B. Dai, Yi-jun Shen, Ying Cai, 2014, Tumor Biology.

Functional variants of the 5-methyltetrahydrofolate-homocysteine methyltransferase gene significantly increase susceptibility to prostate cancer: Results from an ethnic Han Chinese population

B. Dai, D. Ye, Hai-Liang Zhang, 2016, Scientific Reports.

Polymorphisms in the mTOR Gene and Risk of Sporadic Prostate Cancer in an Eastern Chinese Population

Q. Wei, D. Ye, Ya-jun Yang, 2013, PloS one.

Polymorphisms at long non-coding RNAs and prostate cancer risk in an eastern Chinese population

Y. Zhu, B. Dai, G. Lin, 2014, Prostate Cancer and Prostatic Disease.

A functional variant in TP63 at 3q28 associated with bladder cancer risk by creating an miR‐140‐5p binding site

Chao Qin, Qiang Ding, Lin Yuan, 2016, International journal of cancer.

Genome-Wide Association Study of Bladder Cancer in a Chinese Cohort Reveals a New Susceptibility Locus at 5q12.3.

Hongbing Shen, Jianfeng Xu, Jielin Sun, 2016, Cancer research.

Genetic score of multiple risk‐associated single nucleotide polymorphisms is a marker for genetic susceptibility to bladder cancer

Jianfeng Xu, Jielin Sun, Hongjie Yu, 2014, Genes, chromosomes & cancer.

ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma

D. Ye, Yao Zhu, G. Shi, 2015, Cancer science.

Validation of the prognostic value of lymph node ratio in patients with penile squamous cell carcinoma: a population-based study

D. Ye, Yao Zhu, C. Gu, 2013, International Urology and Nephrology.

[Comparison of the renal function after partial nephrectomy and radical nephrectomy for T1a renal cell carcinoma].

B. Dai, Yi-jun Shen, D. Ye, 2015, Zhonghua zhong liu za zhi [Chinese journal of oncology].

Inherited mutations in Chinese patients with upper tract urothelial carcinoma

B. Dai, Yi-jun Shen, S. Shariat, 2022, Cell reports. Medicine.

Immune Co-inhibitory Receptors CTLA-4, PD-1, TIGIT, LAG-3, and TIM-3 in Upper Tract Urothelial Carcinomas: A Large Cohort Study

Y. Zhu, C. Gu, Junlong Wu, 2023, Journal of immunotherapy.

Two novel PRKCI polymorphisms and prostate cancer risk in an Eastern Chinese Han population

Q. Wei, D. Ye, Ya-jun Yang, 2015, Molecular carcinogenesis.

Prostate Cancer Screening Using Prostate-Specific Antigen Tests in a High-Risk Population in China: A Cost-Utility Analysis

B. Dai, D. Ye, Yao Zhu, 2021, Current therapeutic research, clinical and experimental.

Surgical treatment of primary disease for penile squamous cell carcinoma: A Surveillance, Epidemiology, and End Results database analysis.

D. Ye, Yao Zhu, C. Gu, 2015, Oncology letters.

Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation

D. Ye, Hai-Liang Zhang, G. Shi, 2021, Frontiers in Oncology.

Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial

Bo Zhang, Zhiquan Hu, Rui Fan, 2023, Chinese medical journal.